Incidence and Onset of Cytomegalovirus Infection in Kidney Transplant Recipients: 3 Months Compared to 6 Months of Prophylaxis

被引：0
|
作者：
West-Thielke, P. [1 ]
Schmiedeskamp, M. [1 ]
Aggarwal, N. [1 ]
Thielke, J. [1 ]
Oberholzer, J. [1 ]
Benedetti, E. [1 ]
机构：
[1] Univ Illinois, Chicago, IL 60680 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1547
引用
收藏
页码：480 / 480
页数：1
相关论文
共 50 条
  • [21] REDUCED INCIDENCE OF CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS RECEIVING EVEROLIMUS
    Tedesco, Helio
    Felipe, Claudia Rosso
    Ferreira, Alexandra Nicolau
    Cristelli, Marina
    De Oliveira, Nagilla Ione
    Mansur, Juliana Busato
    Pestana Jose, Osmar Medina
    TRANSPLANT INTERNATIONAL, 2015, 28 : 247 - 247
  • [22] A study of the Incidence of Cytomegalovirus Infection and Preemptive Therapy in Kidney Transplant Recipients
    Saleem, Zana Sidiq M.
    Abd, Kais H.
    Ibrahim, Nashwan M. R.
    Hussein, Nawfal R.
    Al-Khammas, Hasanain Ma
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2022, 8 (01): : 44 - 46
  • [23] Incidence of cytomegalovirus infection in kidney recipients
    Bilgin, N
    Karakayali, H
    Moray, G
    Akkoc, H
    Turan, M
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2314 - 2315
  • [24] Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis
    Liang, Xinyun
    Famure, Olusegun
    Li, Yanhong
    Kim, S. Joseph
    PROGRESS IN TRANSPLANTATION, 2018, 28 (02) : 124 - 133
  • [25] Incidence of Cytomegalovirus DNAemia in Pediatric Kidney Transplant Recipients After Cessation of Antiviral Prophylaxis
    Chaiyapak, Thanaporn
    Borges, Karlota
    Williams, Angela
    Banh, Tonny
    Vasilevska-Ristovska, Jovanka
    Allen, Upton
    Parekh, Rulan S.
    Hebert, Diane
    TRANSPLANTATION, 2018, 102 (08) : 1391 - 1396
  • [26] Acyclovir prophylaxis of cytomegalovirus disease in kidney transplant recipients
    Vila, A
    Guirado, LL
    Balius, A
    Díaz, M
    Baró, E
    Olaya, M
    Andrade, M
    Agraz, I
    Solá, R
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (06) : 2335 - 2336
  • [27] Early and Late-Onset Cytomegalovirus Infection Following Universal Prophylaxis in Kidney Transplant Recipients: Risk Factors and Outcome
    Tavakol, Matthew
    Ashimine, Satoshi
    Braun, Hillary
    Cleveland, Hayley
    Laszik, Zoltan
    Roberts, John
    TRANSPLANTATION, 2022, 106 (09) : S628 - S628
  • [28] Efficacy of 3 Months vs. 6 Months of Valganciclovir Prophylaxis for Heart Transplant Recipients at Intermediate Risk (R plus ) for CMV Complications
    Ortega-Legaspi, J.
    Morris, A.
    Flattery, M.
    Alexy, T.
    Devore, A.
    Maharaj, V.
    Martin, C.
    Maziarz, E.
    Cooper, L.
    Shah, K.
    Molina, M.
    Udeshi, E.
    Shah, P.
    Cole, R. T.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S116 - S117
  • [29] Clinical and Laboratory Characteristics of Early and Late-Onset Cytomegalovirus Infection Following Universal Prophylaxis in Kidney Transplant Recipients
    Tavakol, M. M.
    Lee, B.
    Ashimine, S.
    Crossman, H.
    Park, M.
    Laszik, Z.
    Roberts, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 780 - 780
  • [30] The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir
    Schroeeder, Regina
    Michelon, Tatiana
    Wurdig, Joao
    Fagundes, Iara
    Schio, Sadi
    Sanchez, Leticia
    Camargo, Jose J.
    Sukkienik, Teresa C.
    Pasqualotto, Alessandro C.
    Neumann, Jorge
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (02): : 212 - 214
12345